Back to search

Article

APOA1 as a Potential Therapeutic Target and Novel Biomarker in Lung Adenocarcinoma

2025-08-09

Abstract excerpt

Lung adenocarcinoma (LUAD) represents the predominant subtype of non-small cell lung cancer, with limited survival improvements despite advances in targeted therapies, underscoring the need for novel biomarkers and therapeutic targets. Apolipoprotein A1 (APOA1), a major component of high-density lipoprotein involved in cholesterol transport, has been linked to tumorigenesis. However, its role in LUAD remains uncle...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2a8defbc-7d4d-533a-95e5-d8a4b97f16e0
DOI
10.22541/au.175472291.15215916/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
APOA1 as a Potential Therapeutic Target and Novel Biomarker in Lung AdenocarcinomaDOI 10.22541/au.175472291.15215916/v1
Select a neighboring publication to make it the new centre.